Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Many studies in vitro compared the onset of action, maximum efficacy, and duration of botulinum toxin type A (BoNT/A) preparations.
Objective: In this study, we analyzed the onset of action of BoNT/A preparation free of complexing proteins in patients with upper limb spasticity post stroke up to 30 days after treatment.
Methods: 75 patients affected by Biceps Brachii spasticity were enrolled. Outcome measures were instrumental muscle tone modification (myometric measurement), improvement of Modified Ashworth Scale (MAS), improvement of elbow's passive extension, and improvement of compound muscle action potential (cMAP) evaluated by electroneurography. We analyzed data at t0 (pre-injection), t1 (1 day after), t2 (7 days after), t3 (14 days after), and t4 (30 days after).
Results: All measurements decreased at t2, t3, and t4 with initial improvement at t2 and maximum improvement at t4; no statistical difference at t1 was found.
Conclusion: This study demonstrated the onset of Incobotulinumtoxin A efficacy started after 7 days; this rapid action and efficacy of BoNT/A preparation could improve an intensive rehabilitation program after some days post-injection. Early clinical onset of action could be by the absence of complexing proteins in the preparation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1871527321666220630154404 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Self-propulsive active nematics.
Philos Trans A Math Phys Eng Sci
September 2025
Niels Bohr Institute, University of Copenhagen, Kobenhavn, Capital Region of Denmark 2100, Denmark.
Increasing evidence suggests that active matter exhibits instances of mixed symmetry that cannot be fully described by either polar or nematic formalism. Here, we introduce a minimal model that integrates self-propulsion into the active nematic framework. Our linear stability analyses reveal how self-propulsion shifts the onset of instability, fundamentally altering the dynamical landscape.
View Article and Find Full Text PDFCelecoxib blocks AKT/mTOR in AKT/YapS127A-driven intrahepatic cholangiocarcinoma, activating p21/p27 for cycle arrest and suppressing Mcl-1 for apoptosis.
Chem Biol Interact
September 2025
School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, People's Republic of China; Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, 430065, People's Republic of China; Hubei Shizhen Laboratory, Wuhan,430061, People 's
Intrahepatic cholangiocarcinoma (iCCA) is a malignant liver tumor with insidious onset, limited treatments, and poor prognosis. Recent studies show celecoxib exerts marked cytotoxic effects on cholangiocarcinoma cell lines, suggesting its potential as an iCCA therapy. However, the potential molecular and cellular mechanisms that link celecoxib treatment to its toxicological outcomes remain unclear.
View Article and Find Full Text PDFDynamics in the Transimpedance Matrix and Electrically Evoked Compound Action Potentials in Cochlear Implant Users With a Lateral-Wall Electrode Array.
Ear Hear
September 2025
Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Objectives: In patients with cochlear implants, tools for measuring intracochlear electric environment as well as neural responses to electrical stimulation are widely available. This study aimed to investigate the possible correlation of changes in the responsiveness of the auditory nerve measured by neural response telemetry with changes in the peak and spread of the intracochlear electric field measured by transimpedance matrix (TIM) in patients implanted with straight electrode arrays.
Design: In this retrospective study, we analyzed a cohort of 144 ears of 113 consecutive patients who were implanted with Slim Straight electrode array (Cochlear Ltd.
Cholera epidemiology analysis through the experience of the 1973 Naples epidemic.
Open Med (Wars)
September 2025
University Museum System of Siena (SIMUS), History of Medicine, University of Siena, Siena, Italy.
Background And Objective: The World Health Organization (WHO) appeal of January 15, 2024, stated "The current number, size and concurrence of multiple outbreaks, the spread to areas free of cholera for decades and alarmingly high mortality rates present a major threat to global health security." The current state is extremely worrying, considering the difficulties of countries in dealing with cholera epidemics due to the lack of funding and the difficulty in oral cholera vaccine production and administration. This study aims to analyse the past and current influence of anthropization on cholera onset.
View Article and Find Full Text PDFComparison of clinical manifestations, antimicrobial susceptibility patterns, and carbapenem resistance determinants between Acinetobacter seifertii and Acinetobacter nosocomialis isolated in Taiwan.
J Microbiol Immunol Infect
August 2025
Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address:
Background: Acinetobacter seifertii, a recently identified member of the Acinetobacter calcoaceticus-Acinetobacter baumannii (Acb) complex, has emerged as a cause of severe human infections. It is closely related to Acinetobacter nosocomialis, a major pathogen of the Acb complex. Here, we aimed to explore the clinical and molecular differences between these two species.
View Article and Find Full Text PDF